Madrigal Pharmaceuticals, Inc. (MDGL)

499.57 +2.60 (+0.52%) USD  |  NASDAQ  |  Jan 22, 10:38
More

Madrigal Pharmaceuticals Stock Based Compensation (Quarterly)

Stock Based Compensation (Quarterly) Chart

View Stock Based Compensation (Quarterly) for MDGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Quarterly) Range, Past 5 Years

View Stock Based Compensation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Quarterly) Benchmarks

View Stock Based Compensation (Quarterly) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Eli Lilly & Co. Upgrade
Amgen, Inc. Upgrade
Crinetics Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade